双鹭药业(002038.SZ)：公司富马酸伏诺拉生片已获得药监局批件

Group 1 - The core point of the article is that Shuanglu Pharmaceutical (002038.SZ) has received approval from the drug regulatory authority for its fumaric acid volnorex tablets [1] Group 2 - The approval indicates a significant milestone for the company, potentially enhancing its product portfolio and market presence [1] - This development may lead to increased investor interest and confidence in the company's future growth prospects [1] - The approval aligns with the company's strategy to expand its offerings in the pharmaceutical market [1]